Omega Healthcare Investors, Inc. (NYSE:OHI) announced today the pricing of its $400 million aggregate principal amount of 4.950% senior notes due 2024. The notes will be issued at a price equal to 98.58% of their face value before initial purchasers’ discount. The offering is expected to close on March 11, 2014, subject to customary closing conditions. The notes will be unsecured senior obligations of the Company and will be guaranteed by each of the Company’s subsidiaries that guarantee the Company’s existing notes and credit agreement borrowings. The notes will be offered only to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended, and to non-U.S. persons outside of the United States under Regulation S of the Securities Act. The Company intends to use the net proceeds of the offering to repay a portion of its outstanding term loans and revolving credit facility borrowings. The notes to be issued in this offering have not been registered under the Securities Act, or any applicable state laws. Accordingly, the notes may not be offered or sold in the U.S. or to U.S. persons without registration or an applicable exemption under the Securities Act and applicable state securities laws. In connection with the offering of the notes, the Company will agree to file a registration statement with the Securities and Exchange Commission relating to an offer to exchange the notes for publicly tradeable notes having substantially identical terms in accordance with published SEC interpretations. This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The Company is a real estate investment trust investing in and providing financing to the long-term care industry. At December 31, 2013, the Company owned or held mortgages on 541 skilled nursing facilities, assisted living facilities and other specialty hospitals with approximately 61,178 licensed beds (58,885 available beds) located in 38 states and operated by 49 third-party healthcare operating companies. In addition, the Company has three facilities and one parcel of land currently held for sale.